IMVT vs. AXSM
IMVT (Immunovant, Inc.) and AXSM (Axsome Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, IMVT returned 29.85%/yr vs 35.01%/yr for AXSM. Their 0.36 correlation means their historical movements had little consistent relationship.
Performance
IMVT vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMVT achieves a 51.93% return, which is significantly higher than AXSM's 19.36% return.
IMVT
- 1D
- -2.18%
- 1M
- -0.44%
- 6M
- 48.54%
- YTD
- 51.93%
- 1Y
- 145.83%
- 3Y*
- 18.74%
- 5Y*
- 29.85%
- 10Y*
- —
- ALL TIME*
- 16.27%
AXSM
- 1D
- -7.10%
- 1M
- -10.77%
- 6M
- 18.31%
- YTD
- 19.36%
- 1Y
- 111.60%
- 3Y*
- 41.26%
- 5Y*
- 35.01%
- 10Y*
- 39.83%
- ALL TIME*
- 34.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $153.10M | $171.36M | $209.26M | |
IMVT Immunovant, Inc. | $35.51M | $39.13M | $60.17M |
IMVT vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IMVT Immunovant, Inc. | 51.93% | 2.62% | -41.21% | 137.35% | 108.33% | -81.55% | 191.05% | 11.37% |
AXSM Axsome Therapeutics, Inc. | 19.36% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 15.40% |
Correlation
The correlation between IMVT and AXSM is 0.39, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.39 |
Correlation (3Y) Balances recent behavior with more history. | 0.40 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.37 |
Correlation (All Time) Calculated using the full available price history since Dec 19, 2019 | 0.36 |
Fundamentals
IMVT:
$7.93B
AXSM:
$11.22B
IMVT:
-$2.71
AXSM:
-$3.72
IMVT:
9.23
AXSM:
204.46
IMVT:
$0.00
AXSM:
$708.24M
IMVT:
-$206.00K
AXSM:
$655.82M
IMVT:
-$527.21M
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMVT vs. AXSM — Risk / Return Rank
IMVT
AXSM
IMVT vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IMVT | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.41 | ||
| Sortino ratioReturn per unit of downside risk | -0.27 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.47 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 8.20 | 6.25 | +1.95 |
| Martin ratioReturn relative to average drawdown | 21.37 | 18.02 | +3.35 |
Loading charts...
Drawdowns
IMVT vs. AXSM - Drawdown Comparison
The maximum IMVT drawdown since its inception was -93.59%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for IMVT and AXSM.
Loading charts...
Drawdown Indicators
| IMVT | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.59% | -86.65% | -6.94% |
Max Drawdown (1Y)Largest decline over 1 year | -17.19% | -18.50% | +1.31% |
Max Drawdown (3Y)Largest decline over 3 years | -69.88% | -32.69% | -37.19% |
Max Drawdown (5Y)Largest decline over 5 years | -69.88% | -61.08% | -8.80% |
Max Drawdown (10Y)Largest decline over 10 years | — | -81.26% | — |
Current DrawdownCurrent decline from peak | -26.73% | -14.57% | -12.16% |
Average DrawdownAverage peak-to-trough decline | -53.37% | -39.06% | -14.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.59% | 6.41% | +0.18% |
Volatility
IMVT vs. AXSM - Volatility Comparison
The current volatility for Immunovant, Inc. (IMVT) is 9.73%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 14.94%. This indicates that IMVT experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMVT | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.73% | 14.94% | -5.21% |
Volatility (6M)Calculated over the trailing 6-month period | 44.56% | 28.72% | +15.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.81% | 42.96% | +18.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.72% | 70.11% | +4.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.70% | 90.38% | -12.68% |
Dividends
IMVT vs. AXSM - Dividend Comparison
Neither IMVT nor AXSM has paid dividends to shareholders.
Financials
IMVT vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Immunovant, Inc. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IMVT and AXSM have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXSM has higher volatility (14.94%) compared to IMVT (9.73%). In terms of maximum drawdown, IMVT dropped -93.59% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (2.69 vs 2.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMVT and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer